[1] Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology, 2013; 144, 1252−61. doi:  10.1053/j.gastro.2013.01.068
[2] He Y, Zhou XL, Fan XQ, et al. Disease burden of pancreatic cancer - China, 1990-2019. China CDC Wkly, 2022; 4, 527−31. doi:  10.46234/ccdcw2022.056
[3] Anamag FT, Noori M, Nejadghaderi SA, et al. Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990-2019. Cancer Med, 2023; 12, 10031−44. doi:  10.1002/cam4.5743
[4] Wei YG, Qin ZD, Liao XW, et al. Pancreatic cancer mortality trends attributable to high fasting blood sugar over the period 1990-2019 and projections up to 2040. Front Endocrinol (Lausanne), 2024; 15, 1302436. doi:  10.3389/fendo.2024.1302436
[5] Li DH. Diabetes and pancreatic cancer. Mol Carcinog, 2012; 51, 64−74. doi:  10.1002/mc.20771
[6] Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 2000; 19, 335−51. doi:  10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z
[7] Chernyavskiy P, Little MP, Rosenberg PS. Correlated Poisson models for age-period-cohort analysis. Stat Med, 2018; 37, 405−24. doi:  10.1002/sim.7519
[8] Dong CP, Wu GF, Li H, et al. Type 1 and type 2 diabetes mortality burden: predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019. J Diabetes Investig, 2024; 15, 623−33. doi:  10.1111/jdi.14146
[9] Andersson G, Borgquist S, Jirström K. Hormonal factors and pancreatic cancer risk in women: the Malmö diet and cancer study. Int J Cancer, 2018; 143, 52−62. doi:  10.1002/ijc.31302
[10] He C. Situation of population aging in China and the strategy. China Popul Today, 1996; 13, 17.